Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
New England Journal of Medicine · 03.07.2025 · 393 (1) · 51-61
DOI: 10.1056/nejmoa2415820 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 03.07.2025. Verfasst von Stephen J Nicholls und 23 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Heart Institute, Monash University, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: Anticholesteremic Agents, Cardiovascular Diseases, Cholesterol Ester Transfer Proteins, Cholesterol, LDL. Die Arbeit wurde bisher 111-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NewAmsterdam Pharma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Victorian Heart Institute, Monash University, Clayton, VIC, Australia.
- NewAmsterdam Pharma, Amsterdam.
- Department of Vascular Medicine, University of Amsterdam, Amsterdam.
- Baylor College of Medicine, Houston.
- Texas Heart Institute, Houston.
- Imperial College London, London.
ORCID-Profile: Steven E Nissen
Förderung
- NewAmsterdam Pharma
Zitieren
APA
Nicholls, S. J., Nelson, A. J., Ditmarsch, M., Kastelein, J. J. P., Ballantyne, C. M., Ray, K. K., Navar, A. M., Nissen, S. E., Harada-Shiba, M., Curcio, D. L., Neild, A., Kling, D., Hsieh, A., Butters, J., Ference, B. A., Laufs, U., Banach, M., Mehran, R., Catapano, A. L., …, & BROADWAY Investigators (2025). Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. New England Journal of Medicine, 393(1), 51-61. https://doi.org/10.1056/nejmoa2415820
Vancouver
Nicholls SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, Ballantyne CM, Ray KK, et al. Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. New England Journal of Medicine. 2025;393(1):51-61. doi:10.1056/nejmoa2415820
BibTeX
@article{Nicholls2025,
author = {Nicholls, Stephen J and Nelson, Adam J and Ditmarsch, Marc and Kastelein, John J P and Ballantyne, Christie M and Ray, Kausik K and Navar, Ann Marie and Nissen, Steven E and Harada-Shiba, Mariko and Curcio, Danielle L and Neild, Annie and Kling, Douglas and Hsieh, Andrew and Butters, Julie and Ference, Brian A and Laufs, Ulrich and Banach, Maciej and Mehran, Roxana and Catapano, Alberico L and Huo, Yong and Szarek, Michael and Balinskaite, Violeta and Davidson, Michael H and BROADWAY Investigators, BROADWAY Investigators},
title = {Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {1},
pages = {51--61},
doi = {10.1056/nejmoa2415820}
}
EUVIMED